相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer
A. Font et al.
ANNALS OF ONCOLOGY (2011)
Fine tuning chemotherapy to match BRCA1 status
Melissa Price et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Identification of Breast Tumor Mutations in BRCA1 That Abolish Its Function in Homologous DNA Recombination
Derek J. R. Ransburgh et al.
CANCER RESEARCH (2010)
Targeting DNA repair in breast cancer: A clinical and translational update
Eitan Amir et al.
CANCER TREATMENT REVIEWS (2010)
BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair
Peter J. O'Donovan et al.
CARCINOGENESIS (2010)
Cisplatin Affects the Conformation of Apo Form, not Holo Form, of BRCA1 RING Finger Domain and Confers Thermal Stability
Apichart Atipairin et al.
CHEMISTRY & BIODIVERSITY (2010)
Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry
Michael Groessl et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
Daniel P. Silver et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The UBXN1 Protein Associates with Autoubiquitinated Forms of the BRCA1 Tumor Suppressor and Inhibits Its Enzymatic Function
Foon Wu-Baer et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
BRCA1 and its toolbox for the maintenance of genome integrity
Michael S. Y. Huen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
T. Byrski et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo
Pierfrancesco Tassone et al.
CANCER BIOLOGY & THERAPY (2009)
Towards Antitumor Active trans-Platinum Compounds
Sheena M. Aris et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2009)
Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1
Zhengyi Wu et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2009)
Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound
Angela Casini et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2009)
The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress
Joanna R. Morris et al.
NATURE (2009)
Principles of ubiquitin and SUMO modifications in DNA repair
Steven Bergink et al.
NATURE (2009)
Targeting the ubiquitin system in cancer therapy
Daniela Hoeller et al.
NATURE (2009)
Rapid Recruitment of BRCA1 to DNA Double-Strand Breaks Is Dependent on Its Association with Ku80
Leizhen Wei et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy
Jennifer E. Quinn et al.
CLINICAL CANCER RESEARCH (2007)
Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase
Catherine M. Eakin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
BRCA1/BARD1 ubiquitinate phosphorylated RNA polymerase II
LM Starita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer
M Taron et al.
HUMAN MOLECULAR GENETICS (2004)
Binding and recognition in the assembly of an active BRCA1 /BARD1 ubiquitin-ligase complex
PS Brzovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein
Y Xia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains
DL Mallery et al.
EMBO JOURNAL (2002)
Alkaline hydrolysis of oxaliplatin - Isolation and identification of the oxalato monodentate intermediate
E Jerremalm et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Structure of a BRCA1-BARD1 heterodimeric RING-RING complex
PS Brzovic et al.
NATURE STRUCTURAL BIOLOGY (2001)
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation
R Hashizume et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity
H Ruffner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Slowing of cisplatin aquation in the presence of DNA but not in the presence of phosphate: Improved understanding of sequence selectivity and the roles of monoaquated and diaquated species in the binding of cisplatin to DNA
MS Davies et al.
INORGANIC CHEMISTRY (2000)
分享论文
